APA ציטוט

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., . . . Ribas, A. (2019). Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol.

Citação norma Chicago

Hamid, O., et al. "Five-year Survival Outcomes for Patients With Advanced Melanoma Treated With Pembrolizumab in KEYNOTE-001." Ann Oncol 2019.

ציטוט MLA

Hamid, O., et al. "Five-year Survival Outcomes for Patients With Advanced Melanoma Treated With Pembrolizumab in KEYNOTE-001." Ann Oncol 2019.